Communiqués Theracryf Plc

Actions

EVG

GB00BSVYN304

Marché Fermé - London S.E. Autres places de cotation 17:35:05 05/07/2024			Varia. 5j.	Varia. 1 janv.
0,85 ^GBX	0,00 %		0,00 %	-46,88 %

28/05	RÉSULTATS ET TRANSACTIONS : Les bénéfices de Victorian Plumbing augmentent ; la perte de Xeros se réduit	AN
28/05	THERACRYF PLC : SUSAN FODEN NOMMÉE PRÉSIDENTE, SUCCÉDANT À BARRY CLA...	RE

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Theracryf : Notice of AGM and Proxy Form	21/06	PU
Theracryf : Annual Report and Accounts 2023-24	29/05	PU
Theracryf : Current corporate presentation	29/05	PU
TheraCryf plc - Evgen Pharma plc, Notice of FY results and Presentation via Investor Meet Company	21/05	AQ
Theracryf : Capital Access Group Analyst Research	20/05	PU
Theracryf : Corporate Presenation	10/05	PU
Theracryf : Corporate Presentation	25/04	PU
Evgen Pharma plc - Retail Offer	20/03	AQ
Evgen Pharma plc - Acquisition, Fundraising and Change of Name	20/03	AQ
Evgen Pharma plc - Positive update on SFX-01 in vitro Glioblastoma studies	20/02	AQ
Brain Hemorrhage Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	14/11	AQ
Evgen Pharma plc - Half Year Report to 30 September 2023	01/11	AQ
Evgen Pharma "delighted" with cash position after promising first half	31/10/23	AQ
Evgen Pharma plc - Erasmus Medical Center commences SFX-01 Glioblastoma studies	27/10/23	AQ
Evgen Pharma plc - Directorate Changes, Retirement of Chair, Appointment of Interim Chair and of Interim CFO	06/09/23	AQ
Evgen Pharma plc - Final Clinical Study Report from Phase 1b PK/PD study of new SFX-01 tablet formulation approved	16/08/23	AQ
Evgen Pharma plc - Return of rights to Sulforadex from Juvenescence	03/08/23	AQ
Evgen Pharma plc - Result of AGM and Investor Presentation	24/07/23	AQ
Evgen Pharma CMO highlights "very aggressive" disease on Glioblastoma Awareness Day	20/07/23	AQ
Evgen receives notification of grant success in the Netherlands for Glioblastoma Pre-clinical and Clinical Studies	20/06/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Theracryf Plc

Actions

EVG

GB00BSVYN304

Communiqués

Filtres